Document reference

2014/2759(DEA)  
Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use  
Basic information  

2014/2759(DEA)

DEA - Delegated acts procedure

Supplementing 1999/0134(COD)

Subject
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
Key events  
28/05/2014
Non-legislative basic document published
C(2014)03446
17/07/2014
Initial period for examining delegated act 2 month(s)
16/09/2014
Initial period for examining delegated act extended at Parliament's request by 2 month(s)
17/09/2014
Committee referral announced in Parliament
25/11/2014
Delegated act not objected by Parliament
Technical information  
Procedure reference
2014/2759(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/8/00856
Documentation gateway  
  • European Commission 
    Non-legislative basic document
     
    C(2014)03446  
    28/05/2014
    EC
     
    Document attached to the procedure
     
    C(2015)4742
    06/07/2015
    EC
     
    Document attached to the procedure
     
    C(2015)6791
    05/10/2015
    EC
     
  • All 
    Non-legislative basic document
       
    C(2014)03446  
    28/05/2014
    EC
     
    Document attached to the procedure
       
    C(2015)4742
    06/07/2015
    EC
     
    Document attached to the procedure
       
    C(2015)6791
    05/10/2015
    EC